8.02 USD
-0.63 (-7.28%)
Overall PAVM gets a fundamental rating of 2 out of 10. We evaluated PAVM against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PAVM have multiple concerns. PAVM is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- PAVM had negative earnings in the past year.
- In the past year PAVM has reported a negative cash flow from operations.
- PAVM had negative earnings in 4 of the past 5 years.
- In the past 5 years PAVM always reported negative operating cash flow.
1.2 Ratios
- PAVM has a Return On Assets of -1.56%. This is in the better half of the industry: PAVM outperforms 71.20% of its industry peers.
- PAVM has a better Return On Equity (-1.66%) than 72.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.56% | ||
| ROE | -1.66% | ||
| ROIC | N/A |
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for PAVM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- PAVM has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PAVM has less shares outstanding
- Compared to 1 year ago, PAVM has an improved debt to assets ratio.
2.2 Solvency
- PAVM has an Altman-Z score of 51.28. This indicates that PAVM is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of PAVM (51.28) is better than 99.46% of its industry peers.
- A Debt/Equity ratio of 0.19 indicates that PAVM is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.19, PAVM perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 51.28 |
ROIC/WACCN/A
WACC9.8%
2.3 Liquidity
- A Current Ratio of 0.40 indicates that PAVM may have some problems paying its short term obligations.
- PAVM has a Current ratio of 0.40. This is amonst the worse of the industry: PAVM underperforms 92.93% of its industry peers.
- PAVM has a Quick Ratio of 0.40. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
- PAVM's Quick ratio of 0.40 is on the low side compared to the rest of the industry. PAVM is outperformed by 92.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
- PAVM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -388.28%.
- PAVM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.28%.
- The Revenue has been growing by 81.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-388.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-704.17%
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
3.2 Future
- The Earnings Per Share is expected to decrease by -243.06% on average over the next years. This is quite bad
- PAVM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 142.05% yearly.
EPS Next Y-76.54%
EPS Next 2Y-243.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- PAVM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year PAVM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as PAVM's earnings are expected to decrease with -243.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-243.06%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- PAVM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PAVMED INC / PAVM FAQ
What is the fundamental rating for PAVM stock?
ChartMill assigns a fundamental rating of 2 / 10 to PAVM.
What is the valuation status of PAVMED INC (PAVM) stock?
ChartMill assigns a valuation rating of 0 / 10 to PAVMED INC (PAVM). This can be considered as Overvalued.
Can you provide the profitability details for PAVMED INC?
PAVMED INC (PAVM) has a profitability rating of 1 / 10.
How financially healthy is PAVMED INC?
The financial health rating of PAVMED INC (PAVM) is 3 / 10.